Comparison of the Performance of Skin Prick, ImmunoCAP, and ISAC Tests in the Diagnosis of Patients with Allergy

Int Arch Allergy Immunol 2017;172:215-223

https://doi.org/10.1159/00046432

Griffiths R.L.M. · El-Shanawany T. · Jolles S.R.A. · Selwood C. · Heaps A.G. · Carne E.M. · Williams P.E. 

Abstract

Background: Allergy is diagnosed from typical symptoms, and tests are performed to incriminate the suspected precipitant. Skin prick tests (SPTs) are commonly performed, inexpensive, and give immediate results. Laboratory tests (ImmunoCAP) for serum allergen-specific IgE antibodies are usually performed more selectively. The immuno-solid phase allergen chip (ISAC) enables testing for specific IgE against multiple allergen components in a multiplex assay.

Dr. Robbie Pesek Discusses Food allergy diagnosis and management

Dr. Robbie Pesek Discusses Food allergy diagnosis and management.

ACAAICOLA

Dr. Phil Lieberman discusses the diagnosis and management anaphylaxis

Dr. Phil Lieberman discusses the diagnosis and management anaphylaxis

ACAAICOLA

The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis

Vaccine

Available online 11 September 2017

In Press, Corrected Proof

Review

Author links open overlay panelCristiano Alicino ChiaraPaganinoAndrea Orsi Matteo Astengo CeciliaTrucchi Giancarlo Icardi Filippo Ansaldi

https://doi.org/10.1016/j.vaccine.2017.09.005Get rights and content

Under a Creative Commons license

open access

Highlights
• Since 2010, PCV10 and PCV13 became available for use in children. 

• This meta-analysis assessed the impact PCV10 and PCV13 in pneumonia hospitalization among children. 

• Novel PCVs reduced hospitalization for pneumonia in children 

• Reduction was more pronounced for radiologically confirmed pneumonia with respect to clinically confirmed pneumonia. 

• None of the studies included in this meta-analysis had been designed to directly compare the impact of PCV10 and PCV13.

Findings from an Online Survey Assessing the Burden and Management of Seasonal Allergic Rhinoconjunctivitis in US Patients

May–June, 2017Volume 5, Issue 3, Pages 779–789.e6

Eli O. Meltzer, MDCorrespondence information about the author MD Eli O. MeltzerEmail the author MD Eli O. Meltzer

, 

Judith Rosen Farrar, PhD

, 

Cary Sennett, MD, PhD

Open Access

PlumX Metrics

DOI: http://dx.doi.org/10.1016/j.jaip.2016.10.010

 |

Article Info

• Abstract

• Full Text
• Images
• References

Background

Seasonal allergic rhinoconjunctivitis (SARC) affects ≥16% of the US population annually. Telephone and in-office surveys have demonstrated negative effects of allergic rhinitis (AR) symptoms on sleep, daily activities, productivity, concentration, and emotions.

Abridged version of the AWMF guideline for the medical clinical diagnostics of indoor mould exposure

• Springer Open Choice
• PMC5533814

Allergo Journal International

Allergo J Int. 2017; 26(5): 168–193.

Published online 2017 Feb 28. doi:  10.1007/s40629-017-0013-3

PMCID: PMC5533814

S2K Guideline of the German Society of Hygiene, Environmental Medicine and Preventive Medicine (GHUP) in collaboration with the German Association of Allergists (AeDA), the German Society of Dermatology (DDG), the German Society for Allergology and Clinical Immunology (DGAKI), the German Society for Occupational and Environmental Medicine (DGAUM), the German Society for Hospital Hygiene (DGKH), the German Society for Pneumology and Respiratory Medicine (DGP), the German Mycological Society (DMykG), the Society for Pediatric Allergology and Environmental Medicine (GPA), the German Federal Association of Pediatric Pneumology (BAPP), and the Austrian Society for Medical Mycology (ÖGMM)

Gerhard A. Wiesmüller,1,2 Birger Heinzow,3 Ute Aurbach,4 Karl-Christian Bergmann,5 Albrecht Bufe,6 Walter Buzina,7Oliver A. Cornely,8 Steffen Engelhart,9 Guido Fischer,10 Thomas Gabrio,11 Werner Heinz,12 Caroline E. W. Herr,13,14Jörg Kleine-Tebbe,15 Ludger Klimek,16 Martin Köberle,17 Herbert Lichtnecker,18 Thomas Lob-Corzilius,19 Rolf Merget,20 Norbert Mülleneisen,21 Dennis Nowak,22 Uta Rabe,23 Monika Raulf,20 Hans Peter Seidl,24 Jens-Oliver Steiß,25,26 Regine Szewszyk,27 Peter Thomas,28 Kerttu Valtanen,27 and Julia Hurraß2

Author information ► Copyright and License information ►

Abstract

This article is an abridged version of the AWMF mould guideline “Medical clinical diagnostics of indoor mould exposure” presented in April 2016 by the German Society of Hygiene, Environmental Medicine and Preventive Medicine (Gesellschaft für Hygiene, Umweltmedizin und Präventivmedizin, GHUP), in collaboration with the above-mentioned scientific medical societies, German and Austrian societies, medical associations and experts.

DRESS: What does the emergency physician need to know?

Authors: Matthew Nemero, DO (Resident Physician, SAUSHEC) and Joshua Oliver, MD (EM Attending Physician, SAUSHEC) // Edited by: Alex Koyfman, MD (@EMHighAK) and Brit Long, MD (@long_brit)

Case

A 15-year-old male patient presents to your emergency department with his family complaining of a fever for 3 days and a rash that started on his face and chest that has been spreading for 3 days. Past medical history is significant for 3 ED visits in the past 90 days and a new diagnosis of epilepsy for which he recently started seeing a neurologist and was placed on phenytoin 3 weeks ago.

Vitals: HR 84, BP 122/74, RR 12, T 38.8 (101.8F), SpO2 99% RA

• On physical exam, you palpate enlarged and tender cervical and axillary lymph nodes.
• You note the generalized rash shown below. It does not involve the oral mucosa.

FULL TEXT

James Verbsky, MD, PhD describes the uses of flow cytometry for the diagnosis of primary immunodeficiency.

ACAAICOLA